Gabapentin Related Compound D,
1076198-17-8,
UNII-E5OQO8X4IC,
E5OQO8X4IC,
2-(1-((3-Oxo-2-azaspiro[4.5]decan-2-yl)methyl)cyclohexyl)acetic acid,
(1-(3-Oxo-2-aza-spiro(4.5)dec-2-ylmethyl)-cyclohexyl)-acetic acid,
(1-(3-Oxo-2-aza-spiro[4.5]dec-2-ylmethyl)-cyclohexyl)acetic acid,
Gabapentin Related Material D,
CTK8F0748,
DTXSID70148145,
ZINC22059760,
AKOS027326132,
TRA0030319,
RT-017395,
FT-0668921,
J-001924,
[1-(3-Oxo-2-aza-spiro[4,5]dec-2-ylmethyl)cyclohexyl]acetic Acid,
1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexaneacetic Acid,
Gabapentin impurity D, European Pharmacopoeia (EP) Reference Standard,
Gabapentin Related Compound D, United States Pharmacopeia (USP) Reference Standard,